Plus I know of 4 SH that have emailed Gary over a fortnight ago and not a single reply ... Company doesn't need to value retail as the Share registrar is loaded with Funds and instos plus a large management Holding but its retail investors that moves the SP needle ...
SNT need to prime the market in anticipation of incoming VALUABLE Data.. not just announce it in a vacuum..
Really with no Serious Adverse Events and in the closing stages of Parkinson Disease Trial the market should be aware of Trial Completion and then Data Analysis indication on timeframe for announced results..
Heck there are Parkinson Phase I companies with a $100m MC ...
Many know here, I see SNT 6302 as the Cash Cow, for Medical Use and Cosmetic Use and Gary casually mentioned recently that they (SNT) have been engaging with Cosmetic Surgery Industry representatives.. Plus we have Fiona Wood ,, her track record speaks for itself with commercialisation of Spray on Skin...
Having announcements out of the blue does not allow precharging the market with awareness or creating anticipation to drive up Value... and I'm only here at this desk for one purpose " Making Money" or I'd be out Trout Fishing..
SNT is hitting sixes out of the park with Trialing and Trial results but isn't really hitting single runs with Market Messaging ,, NZT
